A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease.
<h4>Context</h4>Non alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. NAFLD represents a spectrum of liver disease ranging from reversible hepatic steatosis, to non alcoholic steato-hepatitis (NASH) and cirrhosis. The potential role of glucocor...
Saved in:
| Main Authors: | Adeeba Ahmed, Elizabeth Rabbitt, Theresa Brady, Claire Brown, Peter Guest, Iwona J Bujalska, Craig Doig, Philip N Newsome, Stefan Hubscher, Elwyn Elias, David H Adams, Jeremy W Tomlinson, Paul M Stewart |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0029531&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue.
by: Laura L Gathercole, et al.
Published: (2011-01-01) -
Effects of Mifepristone on Nonalcoholic Fatty Liver Disease in a Patient with a Cortisol-Secreting Adrenal Adenoma
by: Enzo Ragucci, et al.
Published: (2017-01-01) -
SFRP2 Is Associated with Increased Adiposity and VEGF Expression.
by: Rachel K Crowley, et al.
Published: (2016-01-01) -
Genetically predicted cortisol levels and risk of venous thromboembolism.
by: Elias Allara, et al.
Published: (2022-01-01) -
Cortisol Secretion in Obesity Revisited: Lower Basal Serum and Salivary Cortisol with Diminished Cortisol Response to the Low Dose ACTH Challenge
by: Yael Sofer, et al.
Published: (2025-01-01)